In silico design of short hairpin RNA (shRNA)Molecules for DNA pol gene of Contagious Ecthyma virus (ORFV)

PDF
DOI: https://doi.org/10.12681/jhvms.29365
Keywords:
In silico knockdown ORFV RNAi shRNA
L ASADI SAMANI
Department of Genetics, Faculty of Science, Shahrekord University, Shahrekord- Iran
B SAFFAR
Department of Genetics, Faculty of Science, Shahrekord University, Shahrekord- Iran Biotechnology Research Institute, Shahrekord University, Shahrekord, Iran
A MOKHTARI
Department of Pathobiology, Faculty of veterinary medicine, Shahrekord University, Shahrekord- Iran
E AREFIAN
Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran
Abstract

Contagious ecthyma is an infectious skin disease of ruminants caused by the ORF virus (ORFV) that is a member of genus Parapoxvirus of the Poxviridae family. In addition to the significant effects on lambs and human, ORFVs have been recently shown to infect other hosts. The disease causes significant economic damages to the sheep industry, so attempts to eliminate it must be taken into.RNA interference (RNAi) is an evolutionarily conserved mechanism in which the expression of homologous target genesis is suppressed by means of double-stranded RNA molecules. Since RNAi can be considered as a therapeutic method for viral gene silencing, we tend to make the most of this capability. The present study aims to design potential shRNAs to knockdown the DNA-polymerase gene coded by ORF025.A significant number of computational methods such as clustal omega website to target alignment, BLAST-NCBI to similarity search, CLC software to secondary structure prediction, BLOCK-iTRNAi Designer and WI siRNA Selection Program and Software to design of shRNA molecules and scoring have been applied for shRNA molecules designing against the ORF025-DNA pol gene of ORFV. Then three shRNA molecules were logically designed against the ORF025-DNA pol gene. In conclusion the present study provides a strong and superior approach for achieving a validated strategy to design an antiviral shRNA molecule that meets many sequence features for efficient ORFV knockdown and treatment at the mRNA level. The efficiency of these anti ORFV shRNAs need to be tested

Article Details
  • Section
  • Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Downloads
Download data is not yet available.
References
Baghban-Kohnehrouz, B., & Nayeri, S. (2016). Design, simplified cloning, and in-silico analysis of multisite small interfering RNA-targeting cassettes. Molecular biology research communications, 5(1), 31.
Barata, P., Sood, A. K., & Hong, D. S. (2016). RNA-targeted therapeutics in cancer clinical trials: Current status and future directions. Cancer treatment reviews, 50, 35-47.
Bergqvist, C., Kurban, M., & Abbas, O. (2017). Orf virus infection. Reviews in medical virology, 27(4), e1932.
Bofill-De Ros, X., & Gu, S. (2016). Guidelines for the optimal design of miRNA-based shRNAs. Methods, 103, 157-166. doi:10.1016/j.ymeth.2016.04.003
Bora, D., Venkatesan, G., Bhanuprakash, V., Balamurugan, V., Prabhu, M., Sankar, M. S., & Yogisharadhya, R. (2011). TaqMan real-time PCR assay based on DNA polymerase gene for rapid detection of Orf infection. Journal of virological methods, 178(1-2), 249-252.
Fakhr, E., Zare, F., & Teimoori-Toolabi, L. (2016). Precise and efficient siRNA design: a key point in competent gene silencing. Cancer Gene Therapy, 23(4), 73-82. doi:10.1038/cgt.2016.4
Fleming, S., Wise, L., & Mercer, A. (2015). Molecular Genetic Analysis of Orf Virus: A Poxvirus That Has Adapted to Skin. Viruses, 7(3), 1505-1539. doi:10.3390/v7031505
Haussecker, D. (2014). Current issues of RNAi therapeutics delivery and development. Journal of controlled release, 195, 49-54.
Hosamani, M., Scagliarini, A., Bhanuprakash, V., McInnes, C. J., & Singh, R. K. (2009). Orf: an update on current research and future perspectives. Expert review of anti-infective therapy, 7(7), 879-893.
J Blake, S., F Bokhari, F., & AJ McMillan, N. (2012). RNA interference for viral infections. Current Drug Targets, 13(11), 1411-1420.
Kanasty, R. L., Whitehead, K. A., Vegas, A. J., & Anderson, D. G. (2012). Action and reaction: the biological response to siRNA and its delivery vehicles. Molecular Therapy, 20(3), 513-524.
Lambeth, L. S., & Smith, C. A. (2013). Short hairpin RNA-mediated gene silencing. In siRNA Design (pp. 205-232): Springer.
Li, J., Song, D., He, W., Bao, Y., Lu, R., Su, G., Gao, F. (2013). Rapid detection of orf virus by loop-mediated isothermal amplification based on the DNA polymerase gene. Archives of virology, 158(4), 793-798.
Manjunath, N., Wu, H., Subramanya, S., & Shankar, P. (2009). Lentiviral delivery of short hairpin RNAs. Advanced drug delivery reviews, 61(9), 732-745.
Matveeva, O. V., Kang, Y., Spiridonov, A. N., Sætrom, P., Nemtsov, V. A., Ogurtsov, A. Y., . . . Shabalina, S. A. (2010). Optimization of duplex stability and terminal asymmetry for shRNA design. PloS one, 5(4), e10180.
Mcintyre, G. J., Yu, Y.-H., Lomas, M., & Fanning, G. C. (2011). The effects of stem length and core placement on shRNA activity. BMC molecular biology, 12(1), 34.
Nandi, S., De, U. K., & Chowdhury, S. (2011). Current status of contagious ecthyma or orf disease in goat and sheep-A global perspective. Small Ruminant Research, 96(2-3), 73-82.
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002). Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes & development, 16(8), 948-958.
Protocol-online. (2009). Retrieved from http://www.protocol-online. org/prot/Protocols/Rules-of-siRNA- design-for-RNA-interference--RNAi--3210.html
Qureshi, A., Tantray, V. G., Kirmani, A. R., & Ahangar, A. G. (2018). A review on current status of antiviral siRNA. Reviews in Medical Virology, 28(4), e1976. doi:10.1002/rmv.1976
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004). Rational siRNA design for RNA interference. Nature biotechnology, 22(3), 326.
Taxman, D. J., Moore, C. B., Guthrie, E. H., & Huang, M. T.-H. (2010). Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown. In RNA therapeutics (pp. 139-156): Springer.
Wang, G., He, W., Song, D., Li, J., Bao, Y., Lu, R., Gao, F. (2014). In vitro RNA interference targeting the DNA polymerase gene inhibits orf virus replication in primary ovine fetal turbinate cells. Archives of virology, 159(5), 915-920.
Yin, R., Ding, Z., Liu, X., Mu, L., Cong, Y., & Stoeger, T. (2010). Inhibition of Newcastle disease virus replication by RNA interference targeting the matrix protein gene in chicken embryo fibroblasts. Journal of virological methods, 167(1), 107-111.
Zeedan, G., Abdalhamed, A., Ghoneim, N., & Ghazy, A. (2015). Isolation and Molecular characterization of Contagious Ecthyma (ORF) Virus from Small Ruminants and Human in Egypt. Journal of Veterinary Advances, 5(10), 1139-1146.
Zhao, Z., Wu, G., Zhu, X., Yan, X., Dou, Y., Li, J., Cai, X. (2012). RNA interference targeting virion core protein ORF095 inhibits Goatpox virus replication in Vero cells. Virology journal, 9(1), 48.